Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,980,022 papers from all fields of science
Search
Sign In
Create Free Account
HER2/Neu Status
Known as:
ERBB2 Status
, Her2/Neu Value
The presence or absence of Her2/Neu on a tissue sample.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Karsinoma in Situ Lezyonları : Histopatolojik özellikler ile p 53 , HER 2 / neu , bcl-2 ve PCNA Ekspresyonu arasındaki ilişki
Murat Tad
,
Sezer Kulaçoğlu
2018
Corpus ID: 73589879
Objective: The histopathological subtype, nuclear grade and comedonecrosis are important features for ductal carcinoma in situ…
Expand
2013
2013
Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup
M. Shekhar
,
I. Kato
,
P. Nangia-Makker
,
L. Tait
OncoTarget
2013
Corpus ID: 16192481
Basal breast cancer comprises ~15% of invasive ductal breast cancers, and presents as high-grade lesions with aggressive clinical…
Expand
2012
2012
Synthesis of Gemcitabine-(C4-amide)-[anti-HER2/neu] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary…
C. Coyne
,
Toni Jones
,
Ryan Bear
Journal of Cancer Therapy
2012
Corpus ID: 9057351
Gemcitabine is a pyrimidine nucleoside analog that becomes triphosphorylated intracellularly where it competitively inhibits…
Expand
2011
2011
Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma.
C. Coyne
,
Toni Jones
,
T. Pharr
Bioorganic & Medicinal Chemistry
2011
Corpus ID: 32005115
2011
2011
Telomere 長解析と, Telomerase, HER2/neu の発現による甲状腺癌の補助診断
杉下 佳之
,
神森 眞
,
+9 authors
山田 哲
2011
Corpus ID: 196208755
2010
2010
Celecoxib and aromatase activity in breast cancer: Results from a prospective randomized preoperative trial.
E. Port
,
K. Subbaramaiah
,
+4 authors
C. Hudis
2010
Corpus ID: 73981037
1527 Background: COX-2 is overexpressed in many epithelial malignancies, including a subset of human breast cancers. Preclinical…
Expand
2009
2009
Changing Therapy as a Consequence of the Behaviour of CETC during Adjuvant Trastuzumab Treatment in Patients with Her2/Neu Positive Breast Cancer.
U. Hammer
,
O. Camara
,
K. Hekimian
,
A. Gellner
,
I. Runnebaum
,
K. Pachmann
2009
Corpus ID: 71895275
Gene silencing, demethylation, translocations and amplifications crucially contribute to the growth potential and aggressiveness…
Expand
2008
2008
Pagetoid dyskeratosis of the nipple epidermis: an incidental finding mimicking Paget's disease of the nipple
M. Garijo
,
D. Val
,
J. Val-Bernal
Acta Pathologica, Microbiologica et Immunologica…
2008
Corpus ID: 32409760
Pagetoid dyskeratosis (PD) is considered a selective keratinocytic response in which a small part of the normal population of…
Expand
2006
2006
Иммуноморфологическая характеристика процесса неоваскуляризации в метастазирующих аденокарциномах желудка с применением маркеров HER2/neu, Ki-67 и р53
В. Т. Зорькин
,
Ф. Лазарева
,
В. В. Климачёв
,
Игорь Петрович Бобров
,
А. М. Авдалян
2006
Corpus ID: 101410385
Review
2006
Review
2006
Circulating HER2/neu
A. Lipton
,
L. Demers
,
+4 authors
W. Carney
2006
Corpus ID: 67976684
The HER2/neu oncogene and its p185 receptor protein is an indicator of a more aggressive form of breast cancer. The HER2/neu…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required